Intensive lifestyle changes after AF ablation in people who are overweight
Official title: Outcome Improvement in Obese Patients With Atrial Fibrillation After Catheter Ablation: Importance of Gut Microbiota Dysbiosis and Adipose Tissue Biology
Run by National Taiwan University Hospital · NCT07618741 · Data updated 2026-11-12
The study tests whether an intensive diet and exercise program after AF ablation helps overweight patients do better than standard follow-up care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years and up |
| Sex | All |
| Enrollment | 520 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | September 16, 2021 |
| Main results expected | May 2030 |
| Study ends | May 2030 |
| Registry record updated | June 1, 2026 |
| Trial ID | NCT07618741 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with paroxysmal or persistent AF scheduled for catheter ablation at National Taiwan University Hospital and who meet local eligibility criteria.
✕Probably not a fit
Patients with unwillingness or inability to participate in follow-up visits or adhere to the lifestyle program may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial enrolls adults with paroxysmal or persistent atrial fibrillation scheduled for catheter ablation at National Taiwan University Hospital. All participants receive standard ablation and guideline-based AF care, then are randomized to either an intensive lifestyle modification program or usual care. The intervention includes dietary counseling for weight loss and a supervised aerobic plus resistance training program, with home-based activity recommendations. Data collected will include clinical and procedural information, rhythm follow-up, biological samples, and imaging metrics to explore links between lifestyle changes, adipose biology, gut microbiota, and post-ablation outcomes. The study aims to determine whether lifestyle modification improves outcomes in obese AF patients undergoing ablation.
Why it matters
Potential benefit: If successful, patients may achieve better rhythm control and overall health after ablation through weight loss and improved fitness.
How similar studies have gone: Prior work suggests lifestyle and weight management can influence AF outcomes, but randomized data in this specific post-ablation obese population are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with Class I indication of catheter ablation of paroxysmal or persistent AF and will undergo catheter ablation at National Taiwan University Hospital. Exclusion Criteria: 1. Informed consent could not be obtained due to personal problem 2. Unwillingness or inability to return for follow-up visits or reason to believe that adherence to follow-up visits wound be irregular 3. Current or scheduled enrollment in other conflicting studies, and 4. Concomitant disease or other medical condition likely to result in death within 6 months
Where it's running
-
National Taiwan University Hospital
Taipei, Taiwan Recruiting
Study contacts
- Study coordinator: Yen Bin, Liu Associate Professor of Medicine, MD, PhD
- Email: yenbin@ntu.edu.tw
- Phone: +886-0972651035
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation
This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.
-
Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation
This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.
-
Weight-loss drugs tirzepatide vs. semaglutide in adults with obesity
This trial tests whether 12 weeks of tirzepatide or semaglutide have different effects on energy balance in adults with obesity but no diabetes.
-
Bachmann’s Bundle Pacing vs Right Atrial Appendage Pacing for AF
This study tests two common atrial pacing methods to see which one is safer over 12 months for people getting a new pacemaker, ICD, or CRT device.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes
This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.